https://www.c-span.org/video/?472571-1/senate-judiciary-committee-meeting-subpoenas-related-fbis-russia-investigation
https://www.theblaze.com/news/who-resumes-hydroxychloroquine-trial
The World Health Organization announced Wednesday that it is set to resume an international trial testing the effectiveness of hydroxychloroquine in treating COVID-19 after the organization had previously suspended the trial over safety concerns.
The decision to resume came after problems were discovered with a leading medical journal's study on the drug that claimed the drug was ineffective against the coronavirus and increased the risk of death in patients.
That study, published in the Lancet on May 22, has since been criticized by more than 100 scientists and clinicians for its use of suspect patient data provided by a tiny U.S. company, Surgisphere, which didn't match with government reporting. The journal's study was also co-authored by Surgisphere's chief executive Sapan Desai.
The journal was forced to issue an "expression of concern" on Tuesday, "to alert readers to the fact that serious scientific questions have been brought to our attention" regarding the study.
https://en.wikipedia.org/wiki/Surgisphere
Surgisphere is a United States healthcare analytics company established in 2008 by Sapan Desai. It provided data, subsequently found to be unreliable, for studies of COVID-19 that were published in The Lancet and The New England Journal of Medicine in 2020.
Surgisphere has three subsidiaries: Surgical Outcomes Collaborative, Vascular Outcomes, and Quartz Clinical. From 2010 to 2013 Surgisphere published an online medical journal, the Journal of Surgical Radiology
https://www.medicineuncensored.com/a-study-out-of-thin-air
Misinformation is bad. Misinformation in medicine is worse. Misinformation from a prestigious medical journal is the worst. Herein is a detailed look at the controversial Lancet study that resulted in the World Health Organization ending worldwide clinical trials on hydroxychloroquine in order to focus on patented therapeutics.
After its publication, a grass-roots investigation by hundreds of physicians and researchers worldwide revealed irreconcilable inconsistencies in the data that The Lancet’s peer-review process overlooked. The study is now found to have inconsistencies with data from national registries of hospitalized COVID-19 patients. The authors continue to hide data sources in a black box controlled by an unknown corporation called Surgisphere.